Explore the future of Digital Healthcare: artificial intelligence, big data, and innovative technologies for health and well-being.
As part of its ongoing commitment to innovation, the synbrAIn team has launched AIDE-X, an acronym for Artificial Intelligence for Early Detection of Lung Diseases from Chest X-ray Images. AIDE-X is a research project aimed at supporting pneumonia detection while also identifying its…
Despite advances in treatments, 30% to 50% of stage III-IV head and neck squamous cell carcinoma (HNSCC) patients relapse within 2 years after treatment. The Big Data to Decide (BD2Decide) project aimed to build a database for prognostic prediction modeling.
In the fields of medicine and healthcare, it is not uncommon for private and public companies to invest significantly in research and new technologies. Not surprisingly, over the past decade, the application of artificial intelligence and machine learning techniques has found fertile ground…
The paper presents and comparatively analyses several deep learning approaches to automatically detect tuberculosis related lesions in lung CTs, in the context of the ImageClef 2020 Tuberculosis task.
Coeliac disease (CD) is frequently underdiagnosed with a consequent heavy burden in terms of morbidity and health care costs. Diagnosis of CD is based on the evaluation of symptoms and anti-transglutaminase antibodies IgA (TGA-IgA) levels, with values above a tenfold increase being the basis of the biopsy-free diagnostic approach suggested by present guidelines.
The health sector has traditionally been one of the early adopters of databases, from the most simple Electronic Health Record (formerly Computer-Based Patient Record) systems in use in general practice, hospitals and intensive care units to big data, multidata based systems used to support diagnosis and care decisions.
This work describes an approach that combines several image processing techniques with the aim of extracting the main lines of fingerprints.
The main surgeries that can be performed in upper and middle rectal cancer are low anterior rectal resection (LAR), lateral colostomy (LC), and extended Hartmann operation with mesorectal excision (EHO). Compared with lateral colostomy, EHO is a curative surgery; it also requires a shorter operative time and has a lower mortality rate than LAR.
